Additional file 4 of Effectiveness of secukinumab in patients with psoriasis and psoriatic arthritis in a Saudi real-world setting

Additional File 4: Pairwise difference in Disease Activity in Psoriatic Arthritis score (DAPSA) among (PsA) and (PsO-PsA) patients from baseline over 12 months receiving Secukinumab (overall, combined with methotrexate or monotherapy, and regarding prior use of biologics)